The global IVF services market was pegged at $12.51 billion in 2018 and is estimated to garner $26.38 billion by 2026, registering a CAGR of +9.8% from 2019 to 2025.
In vitro fertilization (IVF) is a type of assisted reproductive technique in which an egg is artificially fertilized in a laboratory setting and then implanted into the uterus. IVF is one of the widely used treatments for generation by couples, single mothers and LGBT communities with infertility problems. Increasing infertility rates, increasing trends in pregnancy delays, rising IVF success rates, and increasing disposable income worldwide drive the growth of the IVF services market globally. In addition, the introduction of advanced IVF techniques, such as transdermal epidermal sperm aspiration, three parental IVFs, and genetic diagnostics, will help increase the success rate of IVF. However, global IVF market growth is limited by increased costs for IVF in some underdeveloped regions, complications associated with IVF treatment, low awareness, and social stigma for IVF.
For sample copy of this report, please visit at https://healthcareintelligencemarkets.com/request_sample.php?id=32323
Top Profiling Players: – Virtus Health, Monash IVF Wesley Hospital Auchenflower, Fertility First, Flinders Reproductive Medicine Pty Ltd, Fertility Associates, Genea Oxford Fertility Limited, Repromed, SAFE Fertility Center, Bangkok IVF Center (Bangkok Hospital), Bangkok IVF Center, Damai Service Hospital, TMC Fertility Centre, KL Fertility & Gynecology Centre
Regional Outlook: For comprehensive understanding of market dynamics, the IVF Service market is analyzed across key geographies namely: United States, Europe, China, Japan, Southeast Asia, India, and Central & South America
The global IVF services market is broken down by cycle type, end user and region. By type of cycle, the market is divided into a new IVF cycle (non-donor), thawed IVF cycle (non-donor) and donor egg IVF cycle. Thawed IVF cycle (non-donor) segments are expected to have the fastest CAGR of 11.0% during the forecast period. But the new IVF cycle (non-rich) segment dominated the market in 2018, accounting for more than three-fifths of the market.
Based on end users, the market is divided into fertility clinics, hospitals, surgical centers and clinical laboratories. The fertility clinic sector dominated the market in 2017, accounting for more than half of the market. However, the clinical research institutes sector is expected to have the fastest CAGR of 10.4% by 2026.
Markets are analyzed in various regions such as North America, Europe, Asia Pacific and LAMEA. In 2018, the Asia-Pacific region market accounted for more than a third of the market, with the largest share. In addition, the region is expected to record the fastest CAGR of 12.6% during the forecast period.
Avail maximum discount on this report, please visit at https://healthcareintelligencemarkets.com/ask_for_discount.php?id=32323
For any Query or more information please visit at https://healthcareintelligencemarkets.com/enquiry_before_buying.php?id=32323
- A detailed overview of the IVF Service and Equipment Market
- Analysis of dynamic aspects of the market such as drivers, restraints, and opportunities
- It offers insights on the latest technologies and trends
- Major Key questions addressed by various stakeholders
- To study and analyze the global market size, market shares, and profit margin
- Competitive landscape of the global IVF Service and Equipment market
At HealthCare Intelligence Markets
Address: 90, State Office Center,
90, State Street Suite 700,
Albany, NY 12207
Phone: +1 (888) 616-2766